Toronto, ON – July 23, 2026 – Today, BioConnect announced that it has received LenelS2 factory recertification and renewed its standing in the LenelS2 OpenAccess Alliance Program (OAAP). BioConnect's biometric access management platform interfaces with the OnGuard® access control system, enabling organizations to layer biometric authentication — including facial recognition, fingerprint, and card — into their existing OnGuard environments without replacing their core access infrastructure.
"BioConnect has completed required factory testing at LenelS2 to validate the functionality of its interface to the OnGuard system. This integration allows end users to extend the power of OnGuard with biometric identity management, giving security teams a unified view of access events across modalities while maintaining the workflows they already know," said John Marchioli, OAAP product management, LenelS2. “We look forward to their continued involvement in the LenelS2 OpenAccess Alliance Program.”
"For organizations running OnGuard, this recertification means they can deploy BioConnect's biometric layer knowing the integration has been tested and validated end-to-end," said Sayantan Chatterjee, Senior Director, Product Management, BioConnect. "Our customers shouldn't have to choose between best-in-class access control and best-in-class biometrics — this integration delivers both, and the recertification is our continued commitment to that standard."
About BioConnect
BioConnect is a multi-modal biometric access management platform that helps organizations manage and secure access at scale. BioConnect interfaces with access control systems, supporting fingerprint, facial, PIN, and card authentication. BioConnect is headquartered in Toronto, ON, and is a Gentex Corporation company. To learn more, contact our team here.